Compare OFIX & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OFIX | IGR |
|---|---|---|
| Founded | 1987 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.1M | 645.2M |
| IPO Year | N/A | N/A |
| Metric | OFIX | IGR |
|---|---|---|
| Price | $13.38 | $4.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | 205.9K | ★ 747.7K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $818,058,000.00 | N/A |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $5.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.31 | N/A |
| 52 Week Low | $10.24 | $3.88 |
| 52 Week High | $20.48 | $5.70 |
| Indicator | OFIX | IGR |
|---|---|---|
| Relative Strength Index (RSI) | 31.12 | 58.70 |
| Support Level | $13.30 | $4.68 |
| Resistance Level | $14.23 | $4.83 |
| Average True Range (ATR) | 0.56 | 0.08 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 5.29 | 65.66 |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.